医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Charlie Kinemura Joins Foresight Group as a Senior Vice President, SME on Argus Safety Japan

2015年08月18日 AM09:00
このエントリーをはてなブックマークに追加


 

TOKYO

Industry veteran and a leader of Argus Safety Japan (Argus J), Hisayoshi Charlie Kinemura has joined Foresight Group as Senior Vice President. With his in depth knowledge and experiences in the design and implementation of Argus J for numerous clients, Charlie will play a leading role as an SME for Foresight’s Argus J customers.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20150817005370/en/

Charlie Kinemura, SVP of Foresight Group (Photo: Business Wire)

Charlie Kinemura, SVP of Foresight Group (Photo: Business Wire)

“With Charlie’s proven track record of achieving success with his previous assignments on Argus Safety Japan projects, we believe that his deep understanding of Argus J and the Japanese regulations and culture will support Foresight in our efforts to remain a trusted and reliable partner of Pharmaceutical industry in Japan,” said Brian Dinardo, Co-CEO and Director, Foresight.

While at Relsys, the original developer of Argus Safety Suite, as a Product Manager, Charlie, and before him Keisuke (KC) Katsuyama who also has joined Foresight in May of this year, designed and led the development to introduce Argus Safety Japan, which is now widely used by a large number of Japanese Pharma companies. He continued his product strategy work through Oracle after its acquisition of Relsys for multiple releases of Argus J, and also led Oracle’s Japanese life science product strategy as Director. During his work at Oracle as well as his previous position as Vice President, Japan at RxLogix Corporation, he led numerous Argus and Argus J projects successfully for multiple clients.

Charlie holds an Engineer’s degree in Computer Science from San Diego State University as well as an Economics degree from Toyo University, Japan.

About Foresight

Foresight Group is a global management and technology services company focused exclusively on pharmacovigilance and risk management. It offers a full range of services with pharmacovigilance experts in every major pharmaceutical market in the world: North America, Europe and Japan. Its best-in-class partnership with Oracle for the implementation of Oracle Argus Safety Suite coupled with its deep expertise in drug safety lets Foresight offer clients the most comprehensive pharmacovigilance services and solutions available in the industry. All of its services and solutions are delivered with precise, timely and cost-effective execution to help the clients achieve and sustain regulatory compliance and manage risk.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150817005370/en/

CONTACT

Foresight Group Japan K.K.
Mihoko Senda, +81-3-5404-3440
www.foresightgroup.com/j

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Dr. Reddy’s Q4 and FY18 Financial Results
  • 武田薬品が米国臨床腫瘍学会(ASCO)と欧州血液学会(EHA)の年次総会でオンコロジーの広範なポートフォリオとパイプラインのデータを発表
  • ResMed赞助的研究显示,采用居家吸氧与居家无创通气相结合治疗COPD具有成本效益
  • 武田在美国临床肿瘤学会(ASCO)和欧洲血液学会(EHA)年会上重点介绍其强大的肿瘤产品阵容和后续产品线数据
  • AVITA Medical Announces Presentation at ISPOR Meeting Validating Acute Burn Health Economic Model